Analytical Advances in the Ex Vivo Challenge Efficacy Assay

The ex vivo challenge assay is being increasingly used as an efficacy endpoint during early human clinical trials of HIV prevention treatments. There is no standard methodology for the ex vivo challenge assay, although the use of different data collection methods and analytical parameters may impact...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:AIDS Res Hum Retroviruses
Main Authors: Richardson-Harman, Nicola, Parody, Robert, Anton, Peter, McGowan, Ian, Doncel, Gustavo, Thurman, Andrea Ries, Herrera, Carolina, Kordy, Kattayoun, Fox, Julie, Tanner, Karen, Swartz, Glenn, Dezzutti, Charlene S.
Formato: Artigo
Idioma:Inglês
Publicado: Mary Ann Liebert, Inc. 2017
Assuntos:
Virology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5372762/
https://ncbi.nlm.nih.gov/pubmed/27841671
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2016.0073
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares